StockWatch
·
CSB BANK LTD · Q1 FY27 · THE VERDICT

The 26.5% PAT Growth That Doesn't Redeem the Guidance Shortfalls

Year-on-year profit jumped solidly, but loan growth, margins, and ROA all missed guidance. The quarter is worse than the headline suggests—and the market is pricing it that way.

Q1 FY27 resultsCSBBANKCSB Bank Ltd02 Aug 2026 · 6 min read
YoY PAT growth

+26.5%

₹150 Cr vs ₹118.7 Cr Q1 FY26

QoQ PAT decline

-25.6%

₹202 Cr Q4 → ₹150 Cr Q1

ROA vs. guidance

1.09%

vs 1.5% target, -41 bp

NIM vs. guidance

3.66%

vs 3.75–4.0% range, -9 bp

CSB Bank delivered headline growth that looks solid—revenue up 23.7%, PAT up 26.5% year-on-year. But step back. Loan growth came in at 24%, missing the 25% guidance by 100 basis points. ROA slumped to 1.09%, missing the 1.5% target by 41 basis points. Net Interest Margins compressed to 3.66%, below the guided range of 3.75–4.0%. And sequentially, profit collapsed 25.6%, dragging from ₹202 crore in Q4 to ₹150 crore here. This is not a quarter the bank's prior guidance anticipated.

The deposit cost trap

The core problem is structural, not seasonal. CSB's deposit funding is 52% bulk deposits at a cost of funds of 6.5%—expensive, locked in, and squeezing NIM at a time when the bank hasn't yet built its retail franchise (CASA at 19.41%, scheduled to scale only from FY28 onwards). Other income collapsed 7% year-on-year: treasury gains halved from ₹53 crore to ₹3 crore, insurance income cut back due to compliance focus, and processing fees suppressed because gold disbursements fell sharply due to regulatory end-use monitoring implementation. Management frames this as a 'worst-case scenario' for NIM and promises recovery, but the timing is vague, and the recovery path—dependent on deposit mix, rate environment, and retail launch execution—is uncertain.

Funding or liquidity is not a problem for us; LCR is 123%. Taking it further up with this kind of cost of funds is inefficient for the bank.

Claims vs. what holds up

Management's on-call assertions graded against the delivered numbers
Claim on the callDelivered numberVerdict
Loan growth 24% YoY, in line with guidance24% delivered; guidance was 25%Missed by 1 pp
NIM stable at 3.66%, guidance 3.75–4.0% intact3.66% is 9 bp below the low endContradicted—below range
ROA around 1.5% for FY27Q1 delivered 1.09%, -41 bp shortfallContradicted—major miss
ROE target 15% (Lakshman Rekha)12.71% delivered; 229 bp below targetContradicted—significant miss
Q1 is worst-case for NIM, recovery aheadNIM 3.66% vs 3.54% Q1 FY26; QoQ PAT down 25.6%Supported on NIM history, but recovery path unclear
PAT down QoQ due to seasonality and cost flow-throughQoQ decline of 25.6%—sharp even for seasonalityOverstated—magnitude suggests execution challenge

What changed on this call vs. prior guidance

  • NIM guidance repositioned to lower end: now 'around 3.75%' vs prior 3.75–4.0% range

  • ROA floor clarified to 1.3–1.5% (vs prior 'around 1.5%'); management says 'will not go below 1.3%' but offers no recovery path

  • Retail deposits and CASA launch pushed to FY28 (no acceleration announced); leaves 3+ quarters of bulk-funded margin compression

  • Gold portfolio glide path to 30% by 2030 reaffirmed, but no new drivers announced

Where the bull-and-bear case stand

The bull-bear ledger
  • Advances +24% YoY, deposits +26% YoY—both outpacing industry

  • Asset quality stable: NNPA 0.39%, high PCR 77.96%, strong capital (CRAR 19.96%)

  • Technology transformation complete; core banking and transaction systems live

  • SBS 2030 strategy quantified and achievable: gold mix reduction underway, wholesale scaled to 26% of book

  • Reported profit leans on YoY growth, but QoQ collapse -25.6% signals underlying weakness

  • Deposit cost 6.5%, 52% bulk mix—expensive funding until retail franchise scales FY28

  • ROA 1.09%, NIM 3.66%, ROE 12.71% all miss guidance; recovery path and timeline vague

  • Retail assets immaterial after 6 years; franchise launch pushed to FY28; no visible near-term profit lever

  • Other income collapsed -7% YoY; treasury gains down 94% (₹53 Cr→₹3 Cr)

  • Asset quality volatile in SME/BLG; slippages ₹98 Cr Q1 (was ₹200 Cr Q3); recoveries uncertain

The market's verdict

The stock closed the day before results at ₹343.2. On day 1 post-result, it fell 1.47%; by day 3, it was down 1.73%; by day 5, it had fallen 2.83%. The weakness did not fade—it persisted. At ₹329.9, the stock now trades 42.57% below its all-time high of ₹574.4, below its 20-day, 50-day, and 200-day moving averages (₹350.25, ₹354.54, ₹393.84 respectively). RSI at 32.2 signals oversold but not yet capitulation. FII ownership fell from 14.16% in Q3 FY26 to 12.84% in Q4 FY26, a 132-basis-point outflow in the most recent quarter; DII ownership also trimmed slightly (15.63% → 15.22%). Promoter stake stable at 40%. The market is not buying the turnaround narrative; it is pricing uncertainty and near-term margin headwind.

Risks, ranked by how much they should concern a holder

Highest to lowest impact on investment returns

Deposit cost persistence: bulk 52%, cost 6.5%, retail not scaling until FY28

High

NIM compression of 9 bp below guidance is not a quarterly event—it is structural until retail franchise launches. That's 3+ quarters of margin pressure. Recovery is dependent on deposit mix shift and retail CASA/deposits not yet in place.

ROA/profitability recovery uncertain: Q1 1.09% vs 1.5% target, path vague

High

Management softened guidance to '1.3–1.5%' and says 'will not go below 1.3%,' but offered no specific actions or timeline. If ROA doesn't recover to 1.3% by Q4, credibility collapses. This is the number to watch.

Retail franchise delay: 6-year stagnation, now FY28 launch

High

The core strategy (SBS 2030) hinges on retail deposit and asset scaling. If FY28 launch slips again, the entire margin-recovery thesis falls apart. Analysts (Vibhor Talreja, Nest Amplifier) explicitly challenged 6-year visibility gap.

Asset quality volatility in SME/BLG: slippages ₹98 Cr Q1, ₹200 Cr Q3, ₹60 Cr Q4

Medium

Small portfolio magnifies volatility; raised credit bar due to macro/tariff uncertainty. Recoveries promised Q2–Q3 but timing uncertain. If slippages persist or migrate to other segments, NNPA will spike.

Gold regulation tightening: end-use monitoring, RBI guidance on repledger, LTV risk

Medium

54% of portfolio; yield 11.85%; agri gold at 85% LTV (Board guidance to reduce). If regulation tightens further (e.g., LTV caps, yield restrictions), growth and profitability are at risk.

Treasury and other income remain suppressed: down 7% YoY, treasury gains 94% lower

Medium

Management describes as 'conservative,' held AFS book. If interest rates fall further, MTM losses possible. If rates spike, other income likely remains constrained by risk management.

FII outflows accelerating: down 132 bp in last quarter, market cap down 42.5%

Medium

Institutional re-rating lower due to guidance misses and execution uncertainty. Further outflows could exacerbate drawdown and reduce analyst coverage.

Wholesale franchise ROA/RAROC not yet proven: growing 35–40% YoY, costs high, transaction banking immature

Low

Wholesale is 26% of portfolio, slated to grow to 32% by FY30. If unit economics don't improve (RAROC, fee income from transaction banking), the shift from gold-centric to balanced will dilute profitability rather than improve it.

What to watch next

  • 1 · Q2 NIM and deposit mix signals

    Will bulk repricing accelerate (cost of funds moving up)? Will retail deposits start accumulating toward FY28 ramp? If NIM recovers even 2–3 bp QoQ, management credibility rebounds; if it stays flat or compresses, the deposit-cost-pressure narrative hardens.

  • 2 · ROA trajectory through H1 FY27

    Management promised Q1 was 'worst case' and recovery 'same pattern as last year.' Track quarterly ROA: does it move toward 1.3% floor by Q2–Q3? Failure to reach 1.3% by Q3 would invalidate guidance and force downside revision.

  • 3 · Retail franchise launch credentials (FY28)

    By Q4 FY27, management should detail CASA/savings product specs, sales team hiring, branch readiness, and customer acquisition roadmap. Vagueness or further delay signals execution risk and extends the margin-compression window.

  • 4 · Asset quality recovery in SME/BLG

    Are the ₹98 Cr Q1 slippages upgraded in Q2–Q3 as promised? If slippages re-emerge or accelerate, it signals macro headwind (tariffs, supply-chain disruption) persistence and justifies raised credit bar.

  • 5 · Analyst rerating and FII flow reversal

    Does the 42.5% drawdown and FII outflow reverse if management proves NIM/ROA recovery traction? Or do further misses trigger downgrades and deeper cuts?

The honest close

CSB Bank is not a broken company. It has genuine strengths: outpacing industry deposit and advance growth, solid asset quality, a coherent long-term strategy (SBS 2030), and completed technology transformation. But this quarter is a step down, not a step forward. Loan growth, margins, ROA, and ROE all missed guidance. Profitability fell sharply quarter-on-quarter. Deposit cost pressure is structural and persists for 3+ quarters. Retail franchise, the lynch pin of the recovery narrative, is not launching until FY28, and track record over the past 6 years provides little comfort.

The market is pricing this correctly. At 42.5% below all-time high, with FII exiting and the post-result momentum failing to recover, the stock reflects the gap between the headline growth story and the profitability recovery story. Near-term, CSB is a hold at best. The stock will re-rate only when management demonstrates ROA recovery traction (1.3% floor by Q3 FY27), deposit mix beginning to shift (CASA/retail signals), and asset quality stability (no SME slippage re-emergence). Until then, the margin-pressure and execution-risk overhang persists.

The single number to track from here is ROA by Q3 FY27. If it rises to 1.2% or higher, the bear case weakens and the long-term story re-gains traction. If it stays below 1.1%, the guidance-miss pattern extends, and a further downside cut is likely.

Informational and educational content only. Not investment advice.